CA2338996A1 - Pharmaceutical composition having improved taste - Google Patents

Pharmaceutical composition having improved taste Download PDF

Info

Publication number
CA2338996A1
CA2338996A1 CA002338996A CA2338996A CA2338996A1 CA 2338996 A1 CA2338996 A1 CA 2338996A1 CA 002338996 A CA002338996 A CA 002338996A CA 2338996 A CA2338996 A CA 2338996A CA 2338996 A1 CA2338996 A1 CA 2338996A1
Authority
CA
Canada
Prior art keywords
drug
pharmaceutical composition
gelling agent
composition according
containing substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002338996A
Other languages
English (en)
French (fr)
Inventor
Yoshinao Onishi
Hirofumi Doi
Masaaki Odomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2338996A1 publication Critical patent/CA2338996A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
CA002338996A 1998-07-31 1999-07-26 Pharmaceutical composition having improved taste Abandoned CA2338996A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10/217517 1998-07-31
JP21751798 1998-07-31
PCT/JP1999/004046 WO2000006122A1 (en) 1998-07-31 1999-07-26 Pharmaceutical composition having improved taste

Publications (1)

Publication Number Publication Date
CA2338996A1 true CA2338996A1 (en) 2000-02-10

Family

ID=16705487

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002338996A Abandoned CA2338996A1 (en) 1998-07-31 1999-07-26 Pharmaceutical composition having improved taste

Country Status (10)

Country Link
EP (1) EP1100466A1 (pt)
KR (1) KR20010072151A (pt)
CN (1) CN1161106C (pt)
AR (1) AR019485A1 (pt)
AU (1) AU4802699A (pt)
BR (1) BR9912533A (pt)
CA (1) CA2338996A1 (pt)
HK (1) HK1040191A1 (pt)
ID (1) ID28910A (pt)
WO (1) WO2000006122A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207930A (pt) 2001-03-05 2004-03-02 Ortho Mcneil Pharm Inc Composições farmacêuticas lìquidas com sabor mascarado
ATE391496T1 (de) 2001-03-05 2008-04-15 Ortho Mcneil Pharm Inc Geschmacksmaskierte pharmazeutische formulierungen
DE602004025113D1 (de) * 2003-07-11 2010-03-04 Astrazeneca Ab Feste zusammensetzung mit einem protonenpumpenhemmer
CN100435847C (zh) * 2004-05-13 2008-11-26 宝龄富锦生技股份有限公司 含有难溶解性主药之持续释放配方
EP1757268B1 (en) 2004-06-07 2017-07-05 Kureha Corporation Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
WO2011149814A2 (en) * 2010-05-24 2011-12-01 Amerilab Technologies, Inc. Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition
JP5976657B2 (ja) 2011-09-30 2016-08-24 持田製薬株式会社 易服用性固形製剤
JP7080215B2 (ja) * 2017-02-21 2022-06-03 Ｅａファーマ株式会社 顆粒製剤
FR3101546B1 (fr) 2019-10-07 2023-11-10 Roquette Freres Masquage du goût de l’isosorbide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
DK0826376T3 (da) * 1995-05-02 2007-04-16 Taisho Pharmaceutical Co Ltd Sammensætning til oral indgivelse
ATE283038T1 (de) * 1995-07-21 2004-12-15 Daiichi Seiyaku Co Verfahren zu herstellung einer granulären zubereitung
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives

Also Published As

Publication number Publication date
AR019485A1 (es) 2002-02-20
HK1040191A1 (zh) 2002-05-31
KR20010072151A (ko) 2001-07-31
CN1161106C (zh) 2004-08-11
EP1100466A1 (en) 2001-05-23
ID28910A (id) 2001-07-12
CN1316899A (zh) 2001-10-10
WO2000006122A1 (en) 2000-02-10
AU4802699A (en) 2000-02-21
BR9912533A (pt) 2002-02-13

Similar Documents

Publication Publication Date Title
US6277412B1 (en) Pellet-type formulation intended for treating the intestinal tract
EP0984774B1 (en) Gastroretentive controlled release microspheres for improved drug delivery
AU760006B2 (en) Method for making granules with masked taste and instant release of the active particle
JP2000509399A (ja) 味隠蔽された懸濁液
HU227381B1 (en) Pharmaceutical composition containing slightly water-soluble drugs with immediate release core and instained release coating
JP2003508428A (ja) 徐放される経口医薬投薬形
JP2005516020A (ja) ゼロ次持続放出剤形およびその製造方法
IL177402A (en) Composition for oral administration of tamsulosin hydrochloride
RU2237480C2 (ru) Непосредственно прессуемая матрица для регулируемого высвобождения однократных ежедневных доз кларитромицина
WO2002096466A1 (en) Medicinal composition
JP2000103730A (ja) 服用感が改善された医薬組成物
AU2005261958A1 (en) Granules for controlled release of Tamsulosin
CA2338996A1 (en) Pharmaceutical composition having improved taste
EP0378137A2 (de) Neue Arzneiform
JP2000191519A (ja) 薬効成分の不快な官能的性質が隠蔽された速放性粒状物
JP5046463B2 (ja) 徐放性医薬組成物
US7063864B1 (en) Morphine sulphate microgranules, method for preparing same and compositions containing same
JP2007518670A (ja) 苦味のある薬物、及びｐＨ感受性ポリマーを含む風味マスクされた医薬組成物
EP1194124B1 (en) Taste masked compositions
US7060293B1 (en) Powder-layered oral dosage forms
AU732210B2 (en) Colonic delivery of weak acid drugs
EP1600157A1 (en) Enteric sustained-release fine particles for tamsulosin or its salt and process for producing the same
US20040253309A1 (en) Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof
AU6224699A (en) Taste masking coating compositions
KR20030076634A (ko) 의약 조성물

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead